Molecule of the Week
November 1, 2010
Rosiglitazone is an antidiabetic drug. The maleic acid salt of its racemic mixture is sold by GlaxoSmithKline under the trade name Avandia. In July, the FDA voted to keep Avandia available despite evidence linking it to an increased risk of heart disease. In September, FDA limited its use, and the European Medicines Agency suspended marketing of the drug.
More about this molecule from CAS, the most authoritative and comprehensive source for chemical information.